一般演題（口演）34 EGFR-TKI耐性

[O34-5] Targeting TNF-α/NF-κB to Overcome Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer

^○Wibowo Adityo¹, Yoichiro Mitsuishi¹, Wira Winardi¹, Fumiyuki Takahashi¹, Hironari Matsuda¹, Daisuke Hayakawa¹, Koichiro Kanamori¹, Ikuko Nakamura¹, Aditya Wirawan¹, Moulid Hidayat¹, Takehito Tsukuya¹, Ken Tajima¹, Takuo Hayashi², Shinji Kohsaka³, Kazuhisa Takahashi¹ (1.Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan, 2.Department of Human Pathology, Juntendo University, Tokyo, Japan, 3.Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan)

アンコール演題